Checkpoint Trends Limited

Equities

RUBRAME6

INE396H01019

Delayed Bombay S.E. Other stock markets 12:15:05 01/07/2024 pm IST			5-day change	1st Jan Change
8.85 ^INR	-1.78%		-6.45%	+90.73%

25/05	Checkpoint Trends Limited Announces Cessation of Sunil Khandalwal as Managing Director, with Effect from May 27, 2024	CI
25/05	Checkpoint Trends Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Already a customer? Log In

Latest news about Checkpoint Trends Limited

Checkpoint Trends Limited Announces Cessation of Sunil Khandalwal as Managing Director, with Effect from May 27, 2024	25/05	CI
Checkpoint Trends Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	25/05	CI
Checkpoint Trends Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	07/02	CI
Checkpoint Trends Limited Announces Resignation of Komal Behl, Company Secretary	25/01	CI
Checkpoint Trends Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	07/11	CI
Checkpoint Trends Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/23/11	CI
Checkpoint Trends Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	26/23/26	CI
Checkpoint Trends Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/23/13	CI
Checkpoint Trends Limited Announces Company Secretary Changes	07/22/07	CI
Checkpoint Trends Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10/22/10	CI
Rubra Medicaments Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	11/22/11	CI
Rubra Medicaments Limited Reports Earnings Results for the Full Year Ended March 31, 2022	25/22/25	CI
Rubra Medicaments Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	25/22/25	CI
Rubra Medicaments Gets Board Approval to Change Name	04/22/04	MT
Rubra Medicaments Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	11/22/11	CI
Rubra Medicaments' Net Profit Soars in Fiscal Q2	11/21/11	MT
Rubra Medicaments Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	11/21/11	CI
Rubra Medicaments Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	13/21/13	CI
Rubra Medicaments Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	29/21/29	CI
Rubra Medicaments Limited Appoints Harish Surve as Independent Director	15/21/15	CI
Rubra Medicaments Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	12/21/12	CI
Rubra Medicaments Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	12/20/12	CI
Rubra Medicaments Limited Announces Appointment of Ms. Ritu Chhatani as Company Secretary and Compliance Officer	21/20/21	CI
Rubra Medicaments Limited Announces the Resignation of Manish Gandhi from the Post of Director	12/20/12	CI
Rubra Medicaments Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	01/20/01	CI